ARRY
Price
$6.12
Change
-$0.25 (-3.92%)
Updated
Jul 13 closing price
Capitalization
942.19M
28 days until earnings call
Intraday BUY SELL Signals
CCCC
Price
$3.92
Change
-$0.14 (-3.45%)
Updated
Jul 13 closing price
Capitalization
433.42M
30 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARRY vs CCCC

ARRY vs CCCC Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ARRY vs. CCCC commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Buy and CCCC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (ARRY: $6.12 vs. CCCC: $3.92)
Brand notoriety: ARRY and CCCC are both not notable
ARRY represents the Alternative Power Generation, while CCCC is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARRY: 64% vs. CCCC: 63%
Market capitalization -- ARRY: $942.19M vs. CCCC: $433.42M
ARRY [@Alternative Power Generation] is valued at $942.19M. CCCC’s [@Biotechnology] market capitalization is $433.42M. The market cap for tickers in the [@Alternative Power Generation] industry ranges from $118.24B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Alternative Power Generation] industry is $2.66B. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARRY’s FA Score shows that 1 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • ARRY’s FA Score: 1 green, 4 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, CCCC is a better buy in the long-term than ARRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 4 TA indicator(s) are bullish while CCCC’s TA Score has 4 bullish TA indicator(s).

  • ARRY’s TA Score: 4 bullish, 6 bearish.
  • CCCC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than ARRY.

Price Growth

ARRY (@Alternative Power Generation) experienced а -12.82% price change this week, while CCCC (@Biotechnology) price change was -5.31% for the same time period.

The average weekly price growth across all stocks in the @Alternative Power Generation industry was -1.96%. For the same industry, the average monthly price growth was -13.61%, and the average quarterly price growth was -10.65%.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

ARRY is expected to report earnings on Aug 11, 2026.

CCCC is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Alternative Power Generation (-1.96% weekly)

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($942M) has a higher market cap than CCCC($433M). CCCC YTD gains are higher at: 105.236 vs. ARRY (-33.623). ARRY has higher annual earnings (EBITDA): 29.6M vs. CCCC (-101.2M). CCCC has more cash in the bank: 236M vs. ARRY (201M). CCCC has less debt than ARRY: CCCC (58.4M) vs ARRY (763M). ARRY has higher revenues than CCCC: ARRY (1.21B) vs CCCC (34.9M).
ARRYCCCCARRY / CCCC
Capitalization942M433M218%
EBITDA29.6M-101.2M-29%
Gain YTD-33.623105.236-32%
P/E Ratio56.91N/A-
Revenue1.21B34.9M3,453%
Total Cash201M236M85%
Total Debt763M58.4M1,307%
FUNDAMENTALS RATINGS
ARRY: Fundamental Ratings
ARRY
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
75
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
70

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARRYCCCC
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 22 days ago
80%
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ARRY
Daily Signal:
Gain/Loss:
CCCC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYOAX69.19N/A
N/A
Rydex Biotechnology H
GGCCX102.34N/A
N/A
Gabelli Growth C
OLGCX50.13N/A
N/A
JPMorgan Large Cap Growth C
SGQCX44.57N/A
N/A
DWS International Opportunities C
DFSPX16.88-0.15
-0.88%
DFA Intl Sustainability Core 1

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with AXON. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-3.45%
AXON - CCCC
40%
Loosely correlated
-3.32%
CELC - CCCC
38%
Loosely correlated
-3.52%
REPL - CCCC
35%
Loosely correlated
-9.60%
WVE - CCCC
35%
Loosely correlated
-4.80%
ARRY - CCCC
35%
Loosely correlated
-3.92%
More